-
Casein Kinase Related Products (93)
Related Products (93)
-
CK2-IN-9
0 ImagesCat. No.: HY-12570CAS No.: 1461658-58-1
-
WAY-353591
0 ImagesCat. No.: HY-148321CAS No.: 454427-09-9WAY-353591 (compound 959) is a Casein kinase 1d inhibitor. WAY-353591 inhibits the tyrosinase enzyme activity with an IC50 value of 131μM. WAY-353591 that can be used in the research of neurodegenerative diseases[1][2].
-
CK1-IN-2 hydrochloride
0 ImagesCat. No.: HY-153866ACAS No.: 1383377-49-8CK1-IN-2 (compound Nr.4) hydrochloride is a potent CK1 inhibitor with an IC50 values of 123, 19.8, 26.8, 74.3 nM for CK1a, CK1d, CK1e, p38a, respectively.
-
Casein kinase 1δ-IN-7
0 ImagesCat. No.: HY-156662CAS No.: 764694-25-9Casein kinase 1δ-IN-7 (compound 497) is a Casein kinase 1δ inhibitor. Casein kinase 1δ-IN-7 can be used in the study of neurodegenerative disorders such as Alzheimer's disease.
-
Casein kinase 1δ-IN-24
0 ImagesCat. No.: HY-169705CAS No.: 326034-30-4Casein kinase 1δ-IN-24 (compound 489) is a potent casein kinase 1δ inhibitor. Casein kinase 1δ-IN-24 can be used in the study of neurodegenerative diseases such as Alzheimer's disease.
-
CK2-IN-11
0 ImagesCat. No.: HY-158370CAS No.: 2938991-22-9
-
Casein kinase 1δ-IN-14
0 ImagesCat. No.: HY-49459CAS No.: 793722-88-0Casein kinase 1δ-IN-14 (compound 481) is a casein kinase inhibitor that can be used to study neurodegenerative diseases such as Alzheimer's disease.
-
Hsp90-Cdc37-IN-4
0 ImagesCat. No.: HY-174347CAS No.: 2758818-41-4Hsp90-Cdc37-IN-4, a Celastrol (HY-13067) derivative, inhibits the Hsp90-Cdc37 protein-protein interaction (PPI). Hsp90-Cdc37-IN-4 selectively inhibits casein kinase 2 (CK2), reducing phosphorylation of its substrate Cdc37 at Serine 13. Hsp90-Cdc37-IN-4 induces G0/G1 cell cycle arrest and triggers apoptosis via the mitochondrial pathway. Hsp90-Cdc37-IN-4 demonstrates potent anti-breast cancer activity.
-
Casein Kinase II Substrate
0 ImagesCasein Kinase II Substrate is a casein kinase II (CK2) peptide substrate that can be selectively phosphorylated by CK2.
-
CK1δ-IN-1
0 ImagesCat. No.: HY-164578CAS No.: 352555-07-8CK1δ-IN-1 (example 939) is a casein kinase 1 delta (CK1δ) inhibitor. CK1δ-IN-1 can be used for the study of Alzheimer's disease.
-
BMS-135-L-Lys
0 ImagesCat. No.: HY-184414BMS-135-L-Lys is a dual-cation prodrug derived from CK2 inhibitor BMS-135 (HY-181022) through esterification with L-lysine using a secondary alcohol. BMS-135-L-Lys achieves enhanced solubility by maintaining protonation of the ε-amino group of the Lys side chain at intestinal pH. BMS-135-L-Lys is released in situ by intestinal wall esterase from the parent drug, significantly increasing the oral bioavailability of the parent drug and overcoming the non-linear pharmacokinetic problem when the dose of the parent drug is increased. BMS-135-L-Lys can be used in related research on colon cancer and lung cancer.
-
Casein kinase 1δ-IN-25
0 ImagesCat. No.: HY-169706CAS No.: 753468-25-6Casein kinase 1δ-IN-25 (compound 487) is a potent casein kinase 1δ inhibitor. Casein kinase 1δ-IN-25 can be used in the study of neurodegenerative diseases such as Alzheimer's disease.
-
CSNK2A-IN-2
0 ImagesCat. No.: HY-163182CAS No.: 3029550-17-9
-
CHX-3107
0 ImagesCat. No.: HY-105222ACAS No.: 127061-56-7CHX-3107 is a casein kinase 2 inhibitor .
-
Casein Kinase Substrates 3
0 ImagesCat. No.: HY-P1909CAS No.: 154444-97-0Casein Kinase Substrates 3 is a substrate of casein kinase.
-
Casein kinase 1δ-IN-19
0 ImagesCat. No.: HY-169689CAS No.: 782452-74-8Casein kinase 1δ-IN-19 (compound 492) is a potent casein kinase 1δ inhibitor. Casein kinase 1δ-IN-19 can be used in the study of neurodegenerative diseases such as Alzheimer's disease.
-
CCK1-specific peptide substrate
0 ImagesCat. No.: HY-P5526CCK1-specific peptide substrate is a biological active peptide. (This peptide sequence is based on rabbit muscle glycogen synthase with Ser7 phosphorylated. It is a peptide substrate for Casein Kinase I (CK1). CK1 phosphorylates Ser10. Ser7 is phosphorylated by PKA in vivo.)
-
CK2-IN-7
0 ImagesCat. No.: HY-153788CAS No.: 2825012-70-0CK2-IN-7 (compound 2) is an inhibitor of casein kinase 2 (CK2). CK2-IN-7 shows synergistic effect with structurally distinct CK2 chemical probe: SGC-CK2-1, against cancer.
